Skip to main content

Table 1 Clinical characteristics of rheumatoid arthritis cases

From: Evaluation of the rheumatoid arthritis susceptibility loci HLA-DRB1, PTPN22, OLIG3/TNFAIP3, STAT4 and TRAF1/C5 in an inception cohort

 

Total RA cohort (n = 1,046)

Autoantibody-positive RA (n = 692)

Autoantibody-negative RA (n = 325)

 

Number of valid subjects

Summary

Number of valid subjects

Summary

Number of valid subjects

Summary

Age (years)

926

59 (14)

411

57 (13)

183

60 (14)

Gender (female)

1046

702 (67%)

692

468 (68%)

325

210 (65%)

Rheumatoid factor-positive

970

628 (65%)

667

628 (94%)

N/A

N/A

Cyclic citrullinated peptide-positive

619

389 (63%)

445

389 (87%)

N/A

N/A

Erosions at baselinea

607

132 (22%)

421

95 (23%)

186

37 (28%)

Swollen joint count at baselinea

648

9.7 (6.2 to 10.2)

447

9.3 (8.8 to 9.9)

186

10.8 (9.8 to 11.8)

Health Assessment Questionnaire at baselinea

648

1.33 (1.27 to 1.39)

447

1.35 (1.28 to 1.42)

186

1.30 (1.19 to 1.41)

  1. Data presented as mean (standard deviation), n (%) or mean (95% confidence interval). N/A, not applicable; RA, rheumatoid arthritis. aSubgroup of individuals with documented symptom duration <24 months.